Cargando…

A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome

Molecular- and cellular-based therapies have the potential to reduce obesity-associated disease. In response to cold, beige adipocytes form in subcutaneous white adipose tissue and convert energy stored in metabolic substrates to heat, making them an attractive therapeutic target. We developed a rob...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Su, Guntur, Anyonya R., Nguyen, Daniel C., Fakory, Shameem S., Doucette, Chad C., Leech, Cassandra, Lotana, Humphrey, Kelley, Matthew, Kohli, Jaspreet, Martino, Julieta, Sims-Lucas, Sunder, Liaw, Lucy, Vary, Calvin, Rosen, Clifford J., Brown, Aaron C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375695/
https://www.ncbi.nlm.nih.gov/pubmed/30540952
http://dx.doi.org/10.1016/j.celrep.2018.11.037
_version_ 1783395409084809216
author Su, Su
Guntur, Anyonya R.
Nguyen, Daniel C.
Fakory, Shameem S.
Doucette, Chad C.
Leech, Cassandra
Lotana, Humphrey
Kelley, Matthew
Kohli, Jaspreet
Martino, Julieta
Sims-Lucas, Sunder
Liaw, Lucy
Vary, Calvin
Rosen, Clifford J.
Brown, Aaron C.
author_facet Su, Su
Guntur, Anyonya R.
Nguyen, Daniel C.
Fakory, Shameem S.
Doucette, Chad C.
Leech, Cassandra
Lotana, Humphrey
Kelley, Matthew
Kohli, Jaspreet
Martino, Julieta
Sims-Lucas, Sunder
Liaw, Lucy
Vary, Calvin
Rosen, Clifford J.
Brown, Aaron C.
author_sort Su, Su
collection PubMed
description Molecular- and cellular-based therapies have the potential to reduce obesity-associated disease. In response to cold, beige adipocytes form in subcutaneous white adipose tissue and convert energy stored in metabolic substrates to heat, making them an attractive therapeutic target. We developed a robust method to generate a renewable source of human beige adipocytes from induced pluripotent stem cells (iPSCs). Developmentally, these cells are derived from FOXF1(+) mesoderm and progress through an expandable mural-like mesenchymal stem cell (MSC) to form mature beige adipocytes that display a thermogenically active profile. This includes expression of uncoupling protein 1 (UCP1) concomitant with increased uncoupled respiration. With this method, dysfunctional adipogenic precursors can be reprogrammed and differentiated into beige adipocytes with increased thermogenic function and anti-diabetic secretion potential. This resource can be used to (1) elucidate mechanisms that underlie the control of beige adipogenesis and (2) generate material for cellular-based therapies that target metabolic syndrome in humans.
format Online
Article
Text
id pubmed-6375695
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-63756952019-02-14 A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome Su, Su Guntur, Anyonya R. Nguyen, Daniel C. Fakory, Shameem S. Doucette, Chad C. Leech, Cassandra Lotana, Humphrey Kelley, Matthew Kohli, Jaspreet Martino, Julieta Sims-Lucas, Sunder Liaw, Lucy Vary, Calvin Rosen, Clifford J. Brown, Aaron C. Cell Rep Article Molecular- and cellular-based therapies have the potential to reduce obesity-associated disease. In response to cold, beige adipocytes form in subcutaneous white adipose tissue and convert energy stored in metabolic substrates to heat, making them an attractive therapeutic target. We developed a robust method to generate a renewable source of human beige adipocytes from induced pluripotent stem cells (iPSCs). Developmentally, these cells are derived from FOXF1(+) mesoderm and progress through an expandable mural-like mesenchymal stem cell (MSC) to form mature beige adipocytes that display a thermogenically active profile. This includes expression of uncoupling protein 1 (UCP1) concomitant with increased uncoupled respiration. With this method, dysfunctional adipogenic precursors can be reprogrammed and differentiated into beige adipocytes with increased thermogenic function and anti-diabetic secretion potential. This resource can be used to (1) elucidate mechanisms that underlie the control of beige adipogenesis and (2) generate material for cellular-based therapies that target metabolic syndrome in humans. 2018-12-11 /pmc/articles/PMC6375695/ /pubmed/30540952 http://dx.doi.org/10.1016/j.celrep.2018.11.037 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Su, Su
Guntur, Anyonya R.
Nguyen, Daniel C.
Fakory, Shameem S.
Doucette, Chad C.
Leech, Cassandra
Lotana, Humphrey
Kelley, Matthew
Kohli, Jaspreet
Martino, Julieta
Sims-Lucas, Sunder
Liaw, Lucy
Vary, Calvin
Rosen, Clifford J.
Brown, Aaron C.
A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome
title A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome
title_full A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome
title_fullStr A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome
title_full_unstemmed A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome
title_short A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome
title_sort renewable source of human beige adipocytes for development of therapies to treat metabolic syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375695/
https://www.ncbi.nlm.nih.gov/pubmed/30540952
http://dx.doi.org/10.1016/j.celrep.2018.11.037
work_keys_str_mv AT susu arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT gunturanyonyar arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT nguyendanielc arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT fakoryshameems arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT doucettechadc arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT leechcassandra arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT lotanahumphrey arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT kelleymatthew arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT kohlijaspreet arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT martinojulieta arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT simslucassunder arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT liawlucy arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT varycalvin arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT rosencliffordj arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT brownaaronc arenewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT susu renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT gunturanyonyar renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT nguyendanielc renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT fakoryshameems renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT doucettechadc renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT leechcassandra renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT lotanahumphrey renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT kelleymatthew renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT kohlijaspreet renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT martinojulieta renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT simslucassunder renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT liawlucy renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT varycalvin renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT rosencliffordj renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome
AT brownaaronc renewablesourceofhumanbeigeadipocytesfordevelopmentoftherapiestotreatmetabolicsyndrome